Clinical Trial Update: Belgian Real Life Non-interventional Study (NIS) on Xarelto in Non-valvular Atrial Fibrillation (AF) Patients Treated for the Prevention of Stroke and Systemic Embolism

View source ↗

Summary

This item reports an update on a Belgian real-world non-interventional study of rivaroxaban (Xarelto) in patients with non-valvular atrial fibrillation for the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Xarelto (rivaroxaban)

Snippet

Sponsor: Bayer | Conditions: Atrial Fibrillation | Status: COMPLETED